June 2013 FDA Recall Drug by Bethel Nutritional Consulting, Inc
D-921-2013 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Bethel Nutritional Consulting, Inc on June 11, 2013 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-921-2013

Reason for Recall
Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.
Initiated
06-11-2013
Reported
09-04-2013
Quantity
18,678 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Bethel Nutritional Consulting, Inc
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide. Product was also available for sale via internet
Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York

Batch or Lot Expiration Information

Lot# : 120514, EXP: 12/2014